106 related articles for article (PubMed ID: 10878873)
1. Routine hepatitis B immunisation in India: cost-effectiveness assessment.
Miller MA; Kane M
Indian J Pediatr; 2000 Apr; 67(4):299-300. PubMed ID: 10878873
[TBL] [Abstract][Full Text] [Related]
2. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
[No Abstract] [Full Text] [Related]
3. Routine hepatitis B immunization in India: cost effectiveness needs reassessment.
Puliyel JM; Mittal R; Tyagi V; Gupta S
Indian J Pediatr; 2003 Feb; 70(2):188. PubMed ID: 12661821
[No Abstract] [Full Text] [Related]
4. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of hepatitis B immunisation strategies.
Hillman AL; Blasco I; Bloom BS; Schwartz JS
Pharmacoeconomics; 1994 Feb; 5(2):85-7. PubMed ID: 10146900
[No Abstract] [Full Text] [Related]
6. Should universal hepatitis B immunisation be introduced in the UK?
English P
Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
[TBL] [Abstract][Full Text] [Related]
7. Desirability and feasibility of hepatitis B vaccine in EPI.
Mittal SK
Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
[No Abstract] [Full Text] [Related]
8. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies.
Edmunds WJ
Commun Dis Public Health; 1998 Dec; 1(4):221-8. PubMed ID: 9854877
[TBL] [Abstract][Full Text] [Related]
9. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
11. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.
Van Damme P; Kane M; Meheus A
BMJ; 1997 Apr; 314(7086):1033-6. PubMed ID: 9112852
[TBL] [Abstract][Full Text] [Related]
12. Universal immunization with hepatitis B vaccine- what it will cost.
Puliyel JM
Indian Pediatr; 2000 Jan; 37(1):107-10. PubMed ID: 10745402
[No Abstract] [Full Text] [Related]
13. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
14. What is the best hepatitis B vaccination strategy for South Africa?
Karim SS
S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
[No Abstract] [Full Text] [Related]
15. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
[TBL] [Abstract][Full Text] [Related]
17. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
Puliyel JM
Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
[No Abstract] [Full Text] [Related]
18. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
Eichhorn R
Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
[No Abstract] [Full Text] [Related]
19. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
20. "Do-nothing" alternative and cost-minimization evaluations.
Agarwal KS
Indian J Gastroenterol; 2004; 23(5):194; author reply 194-5. PubMed ID: 15599014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
